Prosecution Insights
Last updated: October 02, 2026

Examiner: SAEED, ALI S

Tech Center 1600 • Art Units: 1600 1615 1616

This examiner grants 31% of resolved cases

Analysis

Ali S Saeed is an examiner in Tech Center 1600 and Art Unit 1600. The examiner has 131 resolved cases. The allowance rate for these matters is 31.3%. This metric provides a baseline for the likelihood of securing a patent grant during prosecution. The 31.3% rate is a primary data point for evaluating the probability of success in this specific area.

The interview lift is 35.8%. This value measures the increase in the probability of allowance following an interview. A lift of 35.8% indicates that engaging in a direct dialogue with the examiner can be a productive strategy. Practitioners should weigh this 35.8% figure when deciding whether to request a formal interview for their 131 resolved cases.

The median days to allowance is 1478. This figure represents the typical time span from filing to the issuance of a patent. A median of 1478 days informs the scheduling and budget expectations for applicants. This 1478 days duration is a factor in the overall prosecution timeline.

In the assigned Tech Center, the examiner's 31.3% allowance rate and 131 resolved cases define the current landscape. The interview lift serves as a tool for navigating the prosecution process toward a grant.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

31.3%
Allow Rate
-28.7% vs TC avg
205
Total Applications
+35.8%
Interview Lift
1478
Avg Prosecution Days
Based on 131 resolved cases, 2023–2026

Rejection Statute Breakdown

1.8%
§101 Eligibility
7.7%
§102 Novelty
45.6%
§103 Obviousness
23.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
16582710 PHARMACEUTICAL COMPOSITION Non-Final OA MEXICHEM FLUOR S.A. DE C.V.
16582964 PHARMACEUTICAL COMPOSITION Non-Final OA MEXICHEM FLUOR S.A. DE C.V.
16334156 PHARMACEUTICAL COMPOSITION Non-Final OA MEXICHEM FLUOR S.A. DE C.V.
19372848 METHODS FOR MAKING L-GLUFOSINATE Final Rejection BASF SE
19324859 METHODS FOR MAKING L-GLUFOSINATE Final Rejection BASF SE
19258402 METHODS FOR MAKING L-GLUFOSINATE Non-Final OA BASF SE
18723084 TRIAZINE HERBICIDAL COMPOUNDS Non-Final OA SYNGENTA CROP PROTECTION AG
18577424 Herbicidal Compositions Non-Final OA SYNGENTA CROP PROTECTION AG
18551255 CYCLOBUTRIFLURAM SUSPENSION CONCENTRATE COMPOSITION Non-Final OA SYNGENTA CROP PROTECTION AG
18550876 CYCLOBUTRIFLURAM SUSPENSION CONCENTRATE COMPOSITION Non-Final OA SYNGENTA CROP PROTECTION AG
18162387 COMPOSITIONS AND METHODS FOR SUSTAINED OXYGEN RELEASE TO ISCHEMIC TISSUES Final Rejection Washington University
15766586 STABLE PROTEIN COMPOSITIONS Non-Final OA Regeneron Pharmaceuticals, Inc.
18292366 IMPROVED DRUG PROCESSING METHODS TO INCREASE DRUG LOADING Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
17685512 ULTRASOUND MEDIATED POLYMERIZATION FOR CELL DELIVERY, DRUG DELIVERY AND 3D PRINTING Non-Final OA Technion Research & Development Foundation Limited
16761670 INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION Non-Final OA Intervet Inc.
18930238 METHOD OF MANUFACTURING SOLID PHARMACEUTICAL PREPARATION COATED WITH SOLVENT-FREE COATING MATERIAL Non-Final OA Shin-Etsu Chemical Co., Ltd.
18716390 HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION Non-Final OA Conopco, Inc., d/b/a UNILEVER
18255052 MICROCAPSULE AND LIQUID PESTICIDAL FORMULATION Final Rejection SUMITOMO CHEMICAL COMPANY, LIMITED
18722877 SURFACE-COATED PARTICLES Non-Final OA KAO CORPORATION
16894261 COATED POLYMERIC MATERIAL Non-Final OA LifeCell Corporation
18376519 METHOD OF CONTROLLING FUNGAL INFECTIONS IN PLANTS Non-Final OA The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization
16423491 BEAD COMPOSITIONS FOR AQUATIC WEED CONTROL Non-Final OA UPL LTD

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month